Prior to launching her academic career at the École Polytechnique de Montréal, Dr. Hoemann was director of research for five years at a Montreal-based biomedical device company where she invented and developed a medical device for articular cartilage repair that achieved regulatory approval for use in over 17 countries, and was eventually acquired by Smith & Nephew. In 2017, she became a full professor of Bioengineering at George Mason University. Caroline Hoemann is highly regarded internationally for her work on cartilage and cartilage/bone tissue engineering and biomaterial-induced blood and innate immune responses (H-factor of 34, Google Scholar). She is a fellow member of two orthopedic societies (International Cartilage Repair Society, International Combined Orthopedic Research Society), member of the Orthopedic Research society, serves on the editorial board of Cartilage and The Open Orthopaedics Journal, and is a co-founder and on the Board of Directors of ORTHO-RTi, an orthopedic biotech company specializing in implants that stimulate joint tissue repair. Her current research program focuses on understanding how to use biomaterial-guided immune responses to develop novel diagnostics and therapeutics for bone and cartilage regeneration. Her translational research program aims to bring new treatment options to patients with traumatic bone fractures and arthritis.